Find Research Outputs

Search results

• 2019

  Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

  JCOG UOSG, Dec 1 2019, In: The Journal of urology. 202, 6, p. 1127-1135 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Nephroureterectomy
  • Urinary Tract
  • Urinary Bladder Neoplasms
  • Carcinoma
  • Survival
  5 Citations (Scopus)

• Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment

  Umezu, D., Okada, N., Sakoda, Y., Adachi, K., Ojima, T., Yamaue, H., Eto, M. & Tamada, K., Feb 13 2019, In: Cancer Immunology, Immunotherapy. 68, 2, p. 201-211 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Tumor Microenvironment
  • Immunity
  • Monoclonal Antibodies
  • Neoplasms
  • Programmed Cell Death 1 Ligand 2 Protein
  15 Citations (Scopus)

• Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: Study design and rationale

  Grünwald, V., Powles, T., Choueiri, T. K., Hutson, T. E., Porta, C., Eto, M., Sternberg, C. N., Rha, S. Y., He, C. S., Dutcus, C. E., Smith, A., Dutta, L., Mody, K. & Motzer, R. J., Mar 2019, In: Future Oncology. 15, 9, p. 929-941 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • lenvatinib
  • pembrolizumab
  • Sunitinib
  • Everolimus
  • Renal Cell Carcinoma
  13 Citations (Scopus)

• MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma

  Kurahashi, R., Kadomatsu, T., Baba, M., Hara, C., Itoh, H., Miyata, K., Endo, M., Morinaga, J., Terada, K., Araki, K., Eto, M., Schmidt, L. S., Kamba, T., Linehan, W. M. & Oike, Y., Jun 2019, In: Cancer Science. 110, 6, p. 1897-1908 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Renal Cell Carcinoma
  • MicroRNAs
  • Exosomes
  • Biomarkers
  • Transgenic Mice
  11 Citations (Scopus)

• Mirabegron induces relaxant effects via cAMP signaling-dependent and -independent pathways in detrusor smooth muscle

  Maki, T., Kajioka, S., Itsumi, M., Kareman, E., Lee, K., Shiota, M. & Eto, M., Apr 2019, In: LUTS: Lower Urinary Tract Symptoms. 11, 2, p. O209-O217

  Research output: Contribution to journal › Article › peer-review

  • mirabegron
  • Smooth Muscle
  • Swine
  • Carbachol
  • Escin
  3 Citations (Scopus)

• Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses

  Ohyama, C., Kojima, T., Kondo, T., Naya, Y., Inoue, T., Tomita, Y., Eto, M., Hisasue, S., Uemura, H., Obara, W., Kikuchi, E., Sharma, P., Galsky, M. D., Siefker-Radtke, A., Grossfeld, G., Collette, S., Gooden, K. & Kimura, G., Sep 13 2019, In: International Journal of Clinical Oncology. 24, 9, p. 1089-1098 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Nivolumab
  • Carcinoma
  • Advisory Committees
  • Population
  • Confidence Intervals
  5 Citations (Scopus)

• Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study

  Tomita, Y., Fukasawa, S., Shinohara, N., Kitamura, H., Oya, M., Eto, M., Tanabe, K., Saito, M., Kimura, G., Yonese, J., Yao, M. & Uemura, H., May 29 2019, In: Japanese journal of clinical oncology. 49, 6, p. 506-514 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Nivolumab
  • Everolimus
  • Renal Cell Carcinoma
  • Population
  • Confidence Intervals
  15 Citations (Scopus)

• Overview of current and future systemic therapy for metastatic renal cell carcinoma

  Osawa, T., Takeuchi, A., Kojima, T., Shinohara, N., Eto, M. & Nishiyama, H., 2019, In: Japanese journal of clinical oncology. 49, 5, p. 395-403 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Renal Cell Carcinoma
  • Vascular Endothelial Growth Factor A
  • Nivolumab
  • TOR Serine-Threonine Kinases
  • lenvatinib
  11 Citations (Scopus)

• Papillary renal cell carcinoma with massive hematoma mimicking hemangioma

  Hiraki, Y., Okamoto, D., Nishie, A., Asayama, Y., Ishigami, K., Ushijima, Y., Takayama, Y., Fujita, N., Eto, M., Kinoshita, F. & Honda, H., Aug 2019, In: Radiology Case Reports. 14, 8, p. 1003-1006 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hemangioma
  • Renal Cell Carcinoma
  • Hematoma
  • Hemorrhage
  • Tomography
  1 Citation (Scopus)

• Partial nephrectomy for renal tumors

  Tatsugami, K. & Eto, M., Aug 2019, In: Nishinihon Journal of Urology. 81, 4, p. 435-439 5 p.

  Research output: Contribution to journal › Review article › peer-review

  • Nephrectomy
  • Kidney
  • Neoplasms
  • Nephrons
  • Margins of Excision

• Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: Analysis of a nation-wide registry program

  Kume, H., Homma, Y., Shinohara, N., Obara, W., Kondo, T., Kimura, G., Fujimoto, H., Nonomura, N., Hongo, F., Sugiyama, T., Takahashi, M., Kanayama, H. O., Fukumori, T. & Eto, M., Aug 1 2019, In: Japanese journal of clinical oncology. 49, 8, p. 772-779 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Renal Cell Carcinoma
  • Registries
  • Fats
  • Multivariate Analysis
  • Cohort Studies
  1 Citation (Scopus)

• Predictive factors for residual cancer in second transurethral resection for non-muscle-invasive bladder cancer

  Akitake, M., Yamaguchi, A., Shiota, M., Imada, K., Tatsugami, K., Yokomizo, A., Naito, S. & Eto, M., 2019, In: Anticancer research. 39, 8, p. 4325-4328 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Residual Neoplasm
  • Urinary Bladder Neoplasms
  • Carcinoma in Situ
  • Neoplasm Staging
  2 Citations (Scopus)

• Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma

  Inokuchi, J. & Eto, M., 2019, In: Cancer Management and Research. 11, p. 4519-4528 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • pembrolizumab
  • Carcinoma
  • Drug Therapy
  • atezolizumab
  • Platinum
  2 Citations (Scopus)

• Prognostic significance of antihypertensive agents in men with castration-resistant prostate cancer

  Shiota, M., Kobayashi, T., Kashiwagi, E., Takeuchi, A., Inokuchi, J., Tatsugami, K. & Eto, M., Nov 2019, In: Urologic Oncology: Seminars and Original Investigations. 37, 11, p. 813.e21-813.e26

  Research output: Contribution to journal › Article › peer-review

  • Castration
  • Antihypertensive Agents
  • Docetaxel
  • Androgen Receptors
  • Prostatic Neoplasms

• Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer

  Hirata, Y., Shiota, M., Kobayashi, T., Kashiwagi, E., Takeuchi, A., Inokuchi, J., Tatsugami, K. & Eto, M., Dec 2019, In: Prostate International. 7, 4, p. 166-170 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Dyslipidemias
  • Androgens
  • Diabetes Mellitus
  • Prostatic Neoplasms
  • Metabolic Diseases
  1 Citation (Scopus)

• Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with de novo metastatic prostate cancer

  Shiota, M., Namitome, R., Kobayashi, T., Inokuchi, J., Tatsugami, K. & Eto, M., Mar 2019, In: International Journal of Urology. 26, 3, p. 426-428 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  10 Citations (Scopus)

• Psoas muscle volume is correlated with sexual activity and erectile dysfunction among patients with localised prostate cancer

  Kashiwagi, E., Imada, K., Monji, K., Takeuchi, A., Shiota, M., Inokuchi, J., Tatsugami, K. & Eto, M., Oct 1 2019, In: Andrologia. 51, 9, e13354.

  Research output: Contribution to journal › Article › peer-review

  • Psoas Muscles
  • Erectile Dysfunction
  • Sexual Behavior
  • Prostatic Neoplasms
  • Body Composition

• Reconstitution of the embryonic kidney identifies a donor cell contribution to the renal vasculature upon transplantation

  Murakami, Y., Naganuma, H., Tanigawa, S., Fujimori, T., Eto, M. & Nishinakamura, R., Dec 1 2019, In: Scientific reports. 9, 1, 1172.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Transplantation
  • Kidney
  • Endothelial Cells
  • Pluripotent Stem Cells
  • Blood Vessels
  3 Citations (Scopus)

• Serum Prognostic Factors of Androgen-deprivation Therapy among Japanese Men with De Novo Metastatic Prostate Cancer

  Kobayashi, T., Namitome, R., Hirata, Y., Shiota, M., Imada, K., Kashiwagi, E., Takeuchi, A., Inokuchi, J., Tatsugami, K. & Eto, M., 2019, In: Anticancer research. 39, 6, p. 3191-3195 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Androgens
  • Prostatic Neoplasms
  • L-Lactate Dehydrogenase
  • Confidence Intervals
  • Alkaline Phosphatase
  1 Citation (Scopus)

• Serum testosterone level as possible predictive marker in androgen receptor axis-targeting agents and taxane chemotherapies for castration-resistant prostate cancer

  Shiota, M., Kashiwagi, E., Murakami, T., Takeuchi, A., Imada, K., Inokuchi, J., Tatsugami, K. & Eto, M., Mar 2019, In: Urologic Oncology: Seminars and Original Investigations. 37, 3, p. 180.e19-180.e24

  Research output: Contribution to journal › Article › peer-review

  • taxane
  • Castration
  • Androgen Receptors
  • Testosterone
  • Prostatic Neoplasms
  7 Citations (Scopus)

• TFE3 XP11.2 translocation renal cell carcinoma mouse model reveals novel therapeutic targets and identifies GPNMB as a diagnostic marker for human disease

  Baba, M., Furuya, M., Motoshima, T., Lang, M., Funasaki, S., Ma, W., Sun, H. W., Hasumi, H., Huang, Y., Kato, I., Kadomatsu, T., Satou, Y., Morris, N., Karim, B. O., Ileva, L., Kalen, J. D., Krisna, L. A. W., Hasumi, Y., Sugiyama, A., Kurahashi, R. & 12 others, Nishimoto, K., Oyama, M., Nagashima, Y., Kuroda, N., Araki, K., Eto, M., Yao, M., Kamba, T., Suda, T., Oike, Y., Schmidt, L. S. & Marston Linehan, W., Aug 1 2019, In: Molecular Cancer Research. 17, 8, p. 1613-1626 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Renal Cell Carcinoma
  • Therapeutics
  • Biomarkers
  • Kidney
  • N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
  4 Citations (Scopus)

• The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men

  Shiota, M., Fujimoto, N., Tsukahara, S., Ushijima, M., Takeuchi, A., Kashiwagi, E., Inokuchi, J., Tatsugami, K., Uchiumi, T. & Eto, M., Jan 1 2019, In: Cancer chemotherapy and pharmacology.

  Research output: Contribution to journal › Article › peer-review

  • Polymorphism
  • Genetic Polymorphisms
  • Androgens
  • Testosterone
  • Genes
  3 Citations (Scopus)

• Therapeutic outcome of >10 cycles of cabazitaxel for castration-resistant prostate cancer: A Multi-institutional Study

  Shiota, M., Nakamura, M., Yokomizo, A., Tomoda, T., Sakamoto, N., Seki, N., Hasegawa, S., Yunoki, T., Harano, M., Kuroiwa, K. & Eto, M., 2019, In: Anticancer research. 39, 8, p. 4411-4414 4 p.

  Research output: Contribution to journal › Article › peer-review

  • cabazitaxel
  • Castration
  • Prostatic Neoplasms
  • Survival
  • Treatment Failure

• Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan

  Harada, K., Nozawa, M., Uemura, M., Tatsugami, K., Osawa, T., Yamana, K., Kimura, G., Fujisawa, M., Nonomura, N., Eto, M., Shinohara, N., Tomita, Y., Kondo, Y., Ochi, K., Anazawa, Y. & Uemura, H., Feb 1 2019, In: International Journal of Urology. 26, 2, p. 202-210 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Renal Cell Carcinoma
  • Japan
  • Protein-Tyrosine Kinases
  • Phosphotransferases
  • Survival
  11 Citations (Scopus)